🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Study of Personalized Instrument in Total Shoulder Arthroplasty The P.I.T.S.A. Study

RecruitingNAAges 18 Years - 99 YearsAllUniversité de Montréal
NCT03839758 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Total shoulder arthroplasty is an effective procedure to improve patients function and to relieve shoulder pain in cases of glenohumeral arthritis. The main challenge of this procedure is implanting the glenoid component. Indeed, surgical exposure is difficult and proper visualization of the glenoid is demanding. The current free-hand method is not precise and especially unreliable in glenoids with severe deformity. Inappropriate reaming and glenoid positioning can cause more bone loss during surgery. In anatomic prostheses, glenoid component fixation is demanding and is the first component to present loosening at long term follow-up. When it comes to reverse arthroplasty, the glenoid component, once again, requires the most attention. Malpositioning of the glenosphere can cause notching, loosening, and instability. In order to prevent these complications, precision in glenoid implanta

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with shoulder osteaoarthritis and AVN Exclusion Criteria: * Patients with previous shoulder arthroplasty * Patients with inflammatory arthritis and tumor * Patients with previous shoulder surgery with metal implant * Patients refusing 2-year follow-up * Patients that does not speak English or French * Patients with current or previous shoulder infection * Patients with graft during surgery
💊

What it tests

  • TSA standard
  • RTSA standard
  • TSA Blueprint
  • RTSA Blueprint
📍

Where

1 site
Hôpital du Sacré-Cœur de Montréal
Montreal, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy